Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Amit Bar-Or

Showing results (151-160 of 410) with videos related to

Pageof 41
Sort By:
The Journal of Neuroscience : the Official Journal of the Society for Neuroscience|March 11, 2005
Microglial expression of the B7 family member B7 homolog 1 confers strong immune inhibition: implications for immune responses and autoimmunity in the CNSTim Magnus, Bettina Schreiner, Thomas Korn, et al.
Annals of Neurology|June 22, 2023
Early Magnetic Resonance Imaging Features of New Paramagnetic Rim Lesions in Multiple SclerosisKelly A Clark, Abby R Manning, Luyun Chen, et al.
Clinical Immunology (Orlando, Fla.)|April 21, 2016
Differential transcriptional response profiles in human myeloid cell populationsLuke M Healy, Gabrielle Perron, So-Yoon Won, et al.
The Journal of Clinical Endocrinology and Metabolism|June 24, 2011
Cholecalciferol plus calcium suppresses abnormal PBMC reactivity in patients with multiple sclerosisSamantha Kimball, Reinhold Vieth, Hans-Michael Dosch, et al.
Glia|February 1, 2012
Comparison of polarization properties of human adult microglia and blood-derived macrophagesBryce A Durafourt, Craig S Moore, Domenick A Zammit, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|September 16, 2017
Two-year results from a phase 2 extension study of oral amiselimod in relapsing multiple sclerosisLudwig Kappos, Douglas L Arnold, Amit Bar-Or, et al.
Pacific Symposium on Biocomputing. Pacific Symposium on Biocomputing|February 27, 2026
Leveraging Large Language Models to Derive Multiple Sclerosis Progression Assessments from Clinical Notes: A Feasibility StudySy Hwang, Sunil Thomas, Heather Williams, et al.
Multiple Sclerosis and Related Disorders|September 28, 2023
Humoral immune response to COVID-19 mRNA vaccines in patients with relapsing multiple sclerosis treated with ofatumumabAmit Bar-Or, Rany Aburashed, Angel R Chinea, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|September 1, 2021
Long-term safety and efficacy of dimethyl fumarate for up to 13 years in patients with relapsing-remitting multiple sclerosis: Final ENDORSE study resultsRalf Gold, Douglas L Arnold, Amit Bar-Or, et al.
Journal of Immunology (Baltimore, Md. : 1950)|December 16, 2014
Direct and indirect effects of immune and central nervous system-resident cells on human oligodendrocyte progenitor cell differentiationCraig S Moore, Qiao-Ling Cui, Nebras M Warsi, et al.
Pageof 41

Showing results (151-160 of 410) with videos related to

Sort By:
Pageof 41
The Journal of Neuroscience : the Official Journal of the Society for Neuroscience|March 11, 2005
Microglial expression of the B7 family member B7 homolog 1 confers strong immune inhibition: implications for immune responses and autoimmunity in the CNSTim Magnus, Bettina Schreiner, Thomas Korn, et al.
Annals of Neurology|June 22, 2023
Early Magnetic Resonance Imaging Features of New Paramagnetic Rim Lesions in Multiple SclerosisKelly A Clark, Abby R Manning, Luyun Chen, et al.
Clinical Immunology (Orlando, Fla.)|April 21, 2016
Differential transcriptional response profiles in human myeloid cell populationsLuke M Healy, Gabrielle Perron, So-Yoon Won, et al.
The Journal of Clinical Endocrinology and Metabolism|June 24, 2011
Cholecalciferol plus calcium suppresses abnormal PBMC reactivity in patients with multiple sclerosisSamantha Kimball, Reinhold Vieth, Hans-Michael Dosch, et al.
Glia|February 1, 2012
Comparison of polarization properties of human adult microglia and blood-derived macrophagesBryce A Durafourt, Craig S Moore, Domenick A Zammit, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|September 16, 2017
Two-year results from a phase 2 extension study of oral amiselimod in relapsing multiple sclerosisLudwig Kappos, Douglas L Arnold, Amit Bar-Or, et al.
Pacific Symposium on Biocomputing. Pacific Symposium on Biocomputing|February 27, 2026
Leveraging Large Language Models to Derive Multiple Sclerosis Progression Assessments from Clinical Notes: A Feasibility StudySy Hwang, Sunil Thomas, Heather Williams, et al.
Multiple Sclerosis and Related Disorders|September 28, 2023
Humoral immune response to COVID-19 mRNA vaccines in patients with relapsing multiple sclerosis treated with ofatumumabAmit Bar-Or, Rany Aburashed, Angel R Chinea, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|September 1, 2021
Long-term safety and efficacy of dimethyl fumarate for up to 13 years in patients with relapsing-remitting multiple sclerosis: Final ENDORSE study resultsRalf Gold, Douglas L Arnold, Amit Bar-Or, et al.
Journal of Immunology (Baltimore, Md. : 1950)|December 16, 2014
Direct and indirect effects of immune and central nervous system-resident cells on human oligodendrocyte progenitor cell differentiationCraig S Moore, Qiao-Ling Cui, Nebras M Warsi, et al.
Pageof 41